{"id":"https://openalex.org/W3200606416","doi":"https://doi.org/10.1200/jco.2020.39.28_suppl.306","title":"Assessing the representativeness of trial populations for contemporary real-world cancer patients: A case study of adjuvant chemotherapy for colon cancer.","display_name":"Assessing the representativeness of trial populations for contemporary real-world cancer patients: A case study of adjuvant chemotherapy for colon cancer.","publication_year":2021,"publication_date":"2021-09-21","ids":{"openalex":"https://openalex.org/W3200606416","doi":"https://doi.org/10.1200/jco.2020.39.28_suppl.306","mag":"3200606416"},"language":"en","primary_location":{"id":"doi:10.1200/jco.2020.39.28_suppl.306","doi":"https://doi.org/10.1200/jco.2020.39.28_suppl.306","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2020.39.28_suppl.306","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","is_traditional":false,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5030530617","display_name":"Jennifer Leigh Lund","orcid":"https://orcid.org/0000-0002-1108-0689","observed_orcids":["https://orcid.org/0000-0002-1108-0689"]},"institutions":[{"id":"https://openalex.org/I114027177","display_name":"University of North Carolina at Chapel Hill","ror":"https://ror.org/0130frc33","country_code":"US","type":"education","lineage":["https://openalex.org/I114027177"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jennifer Leigh Lund","raw_affiliation_strings":["University of North Carolina at Chapel Hill, Chapel Hill, NC;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of North Carolina at Chapel Hill, Chapel Hill, NC;","institution_ids":["https://openalex.org/I114027177"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5042519493","display_name":"Michael Webster\u2010Clark","orcid":"https://orcid.org/0000-0002-8079-8504","observed_orcids":["https://orcid.org/0000-0002-8079-8504"]},"institutions":[{"id":"https://openalex.org/I114027177","display_name":"University of North Carolina at Chapel Hill","ror":"https://ror.org/0130frc33","country_code":"US","type":"education","lineage":["https://openalex.org/I114027177"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Michael Webster-Clark","raw_affiliation_strings":["University of North Carolina at Chapel Hill, Chapel Hill, NC;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of North Carolina at Chapel Hill, Chapel Hill, NC;","institution_ids":["https://openalex.org/I114027177"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5018209224","display_name":"Emily W. Bratton","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210108991","display_name":"IQVIA (United States)","ror":"https://ror.org/01mk44223","country_code":"US","type":"company","lineage":["https://openalex.org/I4210108991"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Emily W. Bratton","raw_affiliation_strings":["IQVIA, Durham, NC;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"IQVIA, Durham, NC;","institution_ids":["https://openalex.org/I4210108991"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":2,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"39","issue":"28_suppl","first_page":"306","last_page":"306"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11067","display_name":"Colorectal Cancer Treatments and Studies","score":0.7505000233650208,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11067","display_name":"Colorectal Cancer Treatments and Studies","score":0.7505000233650208,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10335","display_name":"Colorectal Cancer Surgical Treatments","score":0.16410000622272491,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11235","display_name":"Statistical Methods in Clinical Trials","score":0.023499999195337296,"subfield":{"id":"https://openalex.org/subfields/2613","display_name":"Statistics and Probability"},"field":{"id":"https://openalex.org/fields/26","display_name":"Mathematics"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/trial-representativeness","display_name":"trial representativeness","score":0.8560000061988831},{"id":"https://openalex.org/keywords/real-world-data","display_name":"real-world data","score":0.6729999780654907},{"id":"https://openalex.org/keywords/adjuvant-chemotherapy","display_name":"adjuvant chemotherapy","score":0.8050000071525574},{"id":"https://openalex.org/keywords/colon-cancer","display_name":"colon cancer","score":0.9459999799728394},{"id":"https://openalex.org/keywords/folfox","display_name":"FOLFOX","score":0.8539999723434448},{"id":"https://openalex.org/keywords/mosaic-trial","display_name":"MOSAIC trial","score":0.9539999961853027},{"id":"https://openalex.org/keywords/electronic-health-records","display_name":"electronic health records","score":0.7940000295639038},{"id":"https://openalex.org/keywords/stage-iii-colon-cancer","display_name":"stage III colon cancer","score":0.6499999761581421},{"id":"https://openalex.org/keywords/prognostic-factors","display_name":"prognostic factors","score":0.8140000104904175},{"id":"https://openalex.org/keywords/ecog-performance-status","display_name":"ECOG performance status","score":0.8600000143051147},{"id":"https://openalex.org/keywords/body-mass-index","display_name":"body mass index","score":0.9089999794960022},{"id":"https://openalex.org/keywords/age-and-sex-differences","display_name":"age and sex differences","score":0.5830000042915344},{"id":"https://openalex.org/keywords/treatment-safety","display_name":"treatment safety","score":0.4189999997615814},{"id":"https://openalex.org/keywords/post-marketing-surveillance","display_name":"post-marketing surveillance","score":0.3330000042915344},{"id":"https://openalex.org/keywords/real-world-safety","display_name":"real-world safety","score":0.5849999785423279}],"concepts":[{"id":"https://openalex.org/C2778260052","wikidata":"https://www.wikidata.org/wiki/Q117636","display_name":"FOLFOX","level":5,"score":0.8834664821624756},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8805168867111206},{"id":"https://openalex.org/C2780962732","wikidata":"https://www.wikidata.org/wiki/Q422327","display_name":"Oxaliplatin","level":4,"score":0.7930454015731812},{"id":"https://openalex.org/C526805850","wikidata":"https://www.wikidata.org/wiki/Q188874","display_name":"Colorectal cancer","level":3,"score":0.6762579679489136},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6427555084228516},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.6085111498832703},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.523078978061676},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.51365727186203}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1200/jco.2020.39.28_suppl.306","doi":"https://doi.org/10.1200/jco.2020.39.28_suppl.306","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2020.39.28_suppl.306","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9940000176429749,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4304989346","https://openalex.org/W3030002941","https://openalex.org/W3193387571","https://openalex.org/W2589985059","https://openalex.org/W3016544133","https://openalex.org/W2683757923","https://openalex.org/W7073735255","https://openalex.org/W2598864273","https://openalex.org/W4380151025","https://openalex.org/W3202059691"],"abstract_inverted_index":{"306":[0],"Background:":[1],"Randomized":[2],"controlled":[3],"trials":[4,27],"are":[5,18,28],"the":[6,11,33,56,110,118,150,188,204,244,256,265,280,341,404],"gold":[7],"standard":[8,151],"for":[9,20,88,294,418],"assessing":[10],"efficacy":[12],"of":[13,32,60,85,114,121,152,210,217,282,302,321,325,331,338,358],"new":[14],"cancer":[15,90,137,162,181,368],"therapies":[16,61],"and":[17,58,74,91,163,200,223,267,277,292,296,380,398,439],"required":[19],"marketing":[21,167],"approval.":[22,168],"However,":[23],"participants":[24,78,327,360],"enrolled":[25,79],"into":[26],"often":[29],"not":[30],"representative":[31],"more":[34,63,389],"diverse":[35],"populations":[36],"in":[37,62,72,80,117,157,187,243,264,336,340,372,403],"whom":[38],"treatment":[39],"will":[40],"ultimately":[41],"be":[42,47],"delivered.":[43],"Real-world":[44],"data":[45,400,413,423,437],"can":[46],"used":[48],"to":[49,165,391],"potentially":[50],"bridge":[51],"this":[52,67],"gap":[53],"by":[54],"evaluating":[55],"effectiveness":[57],"safety":[59],"generalizable":[64],"populations.":[65],"In":[66,203],"study,":[68],"we":[69,171,207,237],"describe":[70],"differences":[71],"demographic":[73],"clinical":[75],"characteristics":[76],"between":[77],"a":[81,92,313,319,347,352,362,377],"phase":[82],"III":[83,135,160,179,286,394],"trial":[84,143,233,266,295,326,359,385],"adjuvant":[86],"chemotherapy":[87],"colon":[89,136,161,180],"contemporary":[93],"comparator":[94,375],"cohort":[95],"using":[96],"structured":[97],"oncology":[98,411],"electronic":[99],"medical":[100],"records":[101],"(EMR)":[102],"data.":[103],"Methods:":[104],"We":[105],"drew":[106],"upon":[107],"publications":[108],"from":[109,128,138],"Multicenter":[111],"International":[112],"Study":[113],"Oxaliplatin/5":[115],"Fluorouracil/Leucovorin":[116],"Adjuvant":[119],"Treatment":[120],"Colon":[122,367],"Cancer":[123],"(MOSAIC)":[124],"recruiting":[125],"patients":[126,173,240,283,305,339,369],"primarily":[127],"Western":[129],"Europe":[130],"with":[131,175,284,312,346],"stage":[132,159,176,216,285,393],"II":[133,177],"or":[134,178],"October":[139],"1998-January":[140],"2001.":[141],"This":[142],"established":[144],"FOLFOX":[145,186,242,371],"(oxaliplatin":[146],"+":[147],"5-FU)":[148],"as":[149,383],"care":[153],"over":[154],"5FU":[155],"alone":[156],"treating":[158],"led":[164],"US":[166,190],"For":[169],"comparison,":[170],"identified":[172,238],"diagnosed":[174],"(September":[182],"2014-2020)":[183],"who":[184],"received":[185],"IQVIA":[189],"Oncology":[191],"EMR":[192,245,268,297,304,342,374,405,412,433],"database":[193],"via":[194,431],"E360,":[195],"IQVIA\u2019s":[196],"Real":[197],"World":[198],"Discovery":[199],"Analytics":[201],"platform.":[202],"two":[205],"populations,":[206],"described":[208],"distributions":[209],"prognostic":[211],"factors":[212],"including":[213],"age,":[214],"sex,":[215],"disease,":[218],"body":[219],"mass":[220],"index":[221],"(BMI),":[222],"Eastern":[224],"Cooperative":[225],"Group":[226],"(ECOG)":[227],"performance":[228],"status.":[229],"Results:":[230],"The":[231],"MOSAIC":[232,384],"included":[234],"2,246":[235],"participants;":[236],"4,566":[239],"starting":[241],"comparator.":[246],"Median":[247],"age":[248,379],"was":[249,273,334],"similar:":[250],"61":[251],"versus":[252,261],"62":[253],"years,":[254],"but":[255,387],"range":[257],"differed":[258,288],"(19-75":[259],"years":[260],"18-85":[262],"years)":[263],"comparator,":[269,298,406],"respectively.":[270,299],"Female":[271],"sex":[272,381],"similar":[274,378],"at":[275,290],"44%":[276],"48%,":[278],"while":[279,323,356],"proportion":[281],"disease":[287],"considerably":[289],"60%":[291],"84%":[293],"Half":[300],"(51%)":[301],"all":[303],"were":[306,388,401],"missing":[307,335],"ECOG":[308,315,330,397],"status;":[309],"among":[310,344],"those":[311,345],"reported":[314,348],"status,":[316],"96%":[317],"had":[318,328,351,361,376],"score":[320],"0-1,":[322],"87%":[324],"an":[329,373,415],"0-1.":[332],"BMI":[333,353,363,399],"34%":[337],"comparator;":[343],"BMI,":[349],"28%":[350],"<":[354,364],"25,":[355],"54%":[357],"25.":[365],"Conclusions:":[366],"receiving":[370],"distribution":[382],"participants,":[386],"likely":[390],"have":[392],"disease.":[395],"Missing":[396],"common":[402],"which":[407],"limited":[408],"comparisons.":[409],"Structured":[410],"represent":[414],"important":[416],"resource":[417],"generating":[419],"real-world":[420],"evidence;":[421],"future":[422],"enrichment":[424],"efforts":[425],"focused":[426],"on":[427],"critical":[428],"patient-level":[429],"variables":[430],"unstructured":[432],"extraction":[434],"may":[435],"improve":[436],"completeness":[438],"quality.":[440]},"counts_by_year":[{"year":2024,"cited_by_count":1},{"year":2023,"cited_by_count":1}],"updated_date":"2026-09-22T06:50:58.402377","created_date":"2021-09-27T00:00:00"}